FDA Updates Warfarin Label to Explain Genetic Links to Response; Says Change Not Meant As 'Directive' for Doctors | GenomeWeb
NEW YORK (GenomeWeb News) - The US Food and Drug Administration said today that the labeling for the widely prescribed anticoagulant warfarin will be updated to explain how people’s genetics may impact their response to the drug.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.